Oncotype Dx Gene Expression Profiling Test

Health Service Executive (HSE) Ireland has Released a tender for Oncotype Dx Gene Expression Profiling Test in Healthcare Equipment and Services. The tender was released on Oct 31, 2024.

Country - Ireland

Summary - Oncotype Dx Gene Expression Profiling Test

Deadline - login to view

MT reference number - 96688206

Product classification - Health and social work services

Organization Details:

  Address - Ireland

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 96688206

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: Gene Expression Profiling (GEP) tests are intended to provide information on disease prognosis and some may also be able to identify thepatients who are most likely to benefit from chemotherapy. In this way they support clinical decision -making regarding a patient’s need foradjuvant chemotherapy. This test is used to inform decision-making in relation to the management of early-stage invasive breast cancer.The Oncotype Dx has been contracted for use in Ireland since 2011.local title:: Oncotype Dx Gene Expression Profiling TestContract Type: : Servicelocal description: : Gene Expression Profiling (GEP) tests are intended to provide information on disease prognosis and some may

Mt Ref Id - 96688206

Deadline - Nov 30, -0001

Share

Similar Tenders :